Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 4/20 | 0.51 |
| ▸ | SRC | P12931 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11101775 | 0.85 | CES1 (0.53) | CES1SRCCES2KCNN4CYP2C19 | |
| SCHEMBL6445934 | 0.83 | CES1 (0.46) | CES1SRCELANECES2KCNN4 | |
| SCHEMBL14800032 | 0.83 | CYP1A2 (0.44) | CES1ELANEKCNN4CYP2C19HIF1A | |
| SCHEMBL5171119 | 0.83 | CYP1A2 (0.44) | CES1ELANEKCNN4CYP2C19HIF1A | |
| SCHEMBL1354212 | 0.83 | CYP1A2 (0.44) | CES1ELANEKCNN4CYP2C19HIF1A | |
| SCHEMBL2814807 | 0.82 | CES1 (0.51) | CES1SRCELANEKCNN4CYP2C19 | |
| SCHEMBL277653 | 0.81 | CES1 (0.65) | CES1SRCCES2KCNN4CYP2C19 | |
| SCHEMBL7154819 | 0.80 | KCNN4 (0.40) | CES1SRCELANEKCNN4CYP2C19 | |
| Methoxymethane SCHEMBL36163 | 0.80 | CES1 (0.62) | CES1SRCCES2KCNN4CYP2C19 | |
| SCHEMBL621110 | 0.79 | CES1 (0.52) | CES1SRCELANECES2KCNN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108676063-A | A kind of double acyloxy bisamide class pharmaceutical intermediates of hydroxyl and preparation method thereof | 三峡大学 | 2018-10-19 | — | — | CN | claimed |
| CN-103228609-B | Method for producing acyloxybenzoic acids | WEIR CHEMICAL SWITZERLAND LTD | 2015-01-07 | — | — | CN | claimed |
| US-5039717-A | Injection molding cookwear | AMOCO CORPORATION (US) | 1991-08-13 | — | — | US | claimed |
| WO-2025072686-A1 | KRAS G12D MUTATION TARGETING COMPOUNDS | SUMMIT THERAPEUTICS INC. (US) | 2025-04-03 | — | — | WO | disclosed |
| WO-2025059556-A1 | COMPOSITIONS COMPRISING PRALATREXATE FOR SUBCUTANEOUS ADMINISTRATION AND METHODS OF USE THEREOF | Acrotech Biopharma Inc. (US) | 2025-03-20 | — | — | WO | disclosed |
| EP-4333903-A1 | COMPOSITIONS AND METHODS RELATED TO THE TREATMENT OF OCULAR DISEASES IN EQUINES | North Carolina State University (US) | 2024-03-13 | — | — | EP | disclosed |
| WO-2023281272-A1 | NASAL SPRAY | Pollinner Limited (GB) | 2023-01-12 | — | — | WO | disclosed |
| WO-2023278827-A1 | 3-IODOPROPYL-1,2,3-TRIAZOL-1-YL, 3-BROMOPROPYL-1,2,3-TRIAZOL-1-YL, AND DERIVATIVES FOR USES IN LABELING | EMORY UNIVERSITY (US) | 2023-01-05 | — | — | WO | disclosed |
| WO-2022235566-A1 | COMPOSITIONS AND METHODS RELATED TO THE TREATMENT OF OCULAR DISEASES IN EQUINES | NORTH CAROLINA STATE UNIVERSITY (US) | 2022-11-10 | — | — | WO | disclosed |
| EP-2599830-B2 | VINYL-CHLORIDE-BASED RESIN COMPOSITION FOR TRANSPARENT PRODUCT | ADEKA CORP (JP) | 2022-09-28 | — | — | EP | disclosed |
| EP-3986879-A1 | FUSED 1,2 THIAZOLES AND 1,2 THIAZINES WHICH ACT AS NL3P3 MODULATORS | AC Immune SA (CH) | 2022-04-27 | — | — | EP | disclosed |
| EP-0330788-A1 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-09-06 | — | — | EP | disclosed |
| EP-0330824-A1 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmias | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-09-06 | — | — | EP | disclosed |
| EP-0329905-A1 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for increasing gastric motility | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329903-A1 | Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of glaucoma | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329904-A1 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of anxiety | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329932-A2 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments | MERRELL PHARMACEUTICALS INC. (US) | 1989-08-30 | — | — | EP | disclosed |
| EP-0284256-A1 | Benzodiazepine analogs | MERCK & CO. INC. (US) | 1988-09-28 | — | — | EP | disclosed |
| EP-0099080-B1 | SUBSTITUTED TETRAHYDROTETRAZOLO(5,1-A)PHTHALAZINES | THE DOW CHEMICAL COMPANY (US) | 1988-02-03 | — | — | EP | disclosed |
| US-4021565-A | Process for the alleviation of depression by administration of non-addicting meperidine analogues | BERGER FRANK M | 1977-05-03 | — | — | US | disclosed |